… cause UTI and their antibiotic susceptibility is mandatory1. Extended spectrum beta lactamases
(ESBL) hydrolyse oxyimino beta lactums like ceftazidime, cephotaxime, ceftriaxone and …

… accounts for 75% to 90% of UTI isolates [2, 17]. The increasing … coli – which represent 36%
of all UTI isolates from two … to each of the four extended spectrum beta-lactams, cefotaxime, …

… Urinary tract infection (UTI) is the second most common … Worldwide, about 150 million
people are diagnosed with UTI … resistance due to extended spectrum beta lactamase (ESBL)-…

… of ESBLs among clinical isolates vary greatly world wide and in geographic areas and are
rapidly changing over time.The occurrence of ESBL producers in urinary isolates of E.coli and …

… Over the past 10 years, the prevalence of extended-spectrum beta-lactamase (ESBL)–positive …
from UTI and the molecular characterization of a subgroup of ESBL-positive isolates from …

… Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are an … to assess
the incidence of ESBL in adults amongst urinary isolates, identify risk factors, and detail the …

… This associated resistance to other classes of antimicrobials is especially problematic in
urinary isolates and underscores the therapeutic challenge that they represent. …

… but as 76% of our ESBL-positive isolates were found to be resistant, this … coli isolate from
Turkey was reported in 2005 and was … caused by extended‐spectrum beta lactamase producing …

… isolated and reported from mid stream urine (MSU) specimens, … extended spectrum
beta-lactamase (ESBL) producers, severely limiting the therapeutic management in cases of urinary …

… -spectrum β-lactamases (ESBLs) is … acquired urinary tract infections has rapidly become
the most common ESBL producing organism. We examined ESBL production in urinary isolates …